z-logo
open-access-imgOpen Access
Maternal 12-Month Response to Antiretroviral Therapy following Prevention of Mother-to-Child Transmission of HIV Type 1, Ivory Coast, 2003- 2006
Author(s) -
Patrick Coffié,
Didier Koumavi Ekouévi,
MarieLaure Chaix,
Besigin TonweGold,
A.-B. Clarisse,
Renaud Becquet,
Ida Viho,
Thérèse N' dri-Yoman,
Valériane Leroy,
Elaine J. Abrams,
C Rouzioux,
François Dabis
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/526780
Subject(s) - zidovudine , nevirapine , medicine , efavirenz , stavudine , lamivudine , virology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , viral disease , virus , hepatitis b virus
Our aim was to study the response to antiretroviral treatment among women exposed to single-dose nevirapine (NVP) and/or short-course zidovudine (ZDV; with or without lamivudine [3TC]) for the prevention of mother-to-child transmission of human immunodeficiency virus (HIV) infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom